ALAB — Astera Labs, Income Statement
0.000.00%
Last trade - 00:00- $34.25bn
- $33.06bn
- $852.53m
Annual income statement for Astera Labs,, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 79.9 | 116 | 396 | 853 |
| Cost of Revenue | ||||
| Gross Profit | 58.7 | 79.8 | 303 | 645 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 140 | 145 | 512 | 679 |
| Operating Profit | -60.2 | -29.5 | -116 | 173 |
| Total Net Non Operating Interest Income / Expense | ||||
| Net Income Before Taxes | -57.6 | -22.9 | -81.8 | 218 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -58.3 | -26.3 | -83.4 | 219 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -58.3 | -26.3 | -83.4 | 219 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -58.3 | -26.3 | -83.4 | 219 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.383 | -0.172 | -0.636 | 1.22 |
| Dividends per Share |